Answers are grounded in this paper and cite their sources.
The promise of genomic medicine has received great attention over the past decade, projecting how genomics will soon guide the prevention, diagnosis, and treatment of human diseases. However, this evolution has been slower than forecast, even where evidence is often strong (e.g., pharmacogenomics). Reasons include the requirement for institutional resources and the need for the will to push beyond barriers impeding health-care changes. Here, we illustrate how genomics has been deployed to advance the treatment of childhood leukemia.
No takes yet. Share an insight, caveat, or question.
Evans et al. (2013) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: